首页 › 慢性淋巴细胞白血病 › 印第安纳州 › Fort Wayne
Fort Wayne IN 慢性淋巴细胞白血病临床试验
7项针对 慢性淋巴细胞白血病的研究正在 Fort Wayne及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
招募中3 期
- Fort Wayne Medical Oncology and Hematology ( Site 5444), Fort Wayne
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
招募中3 期
- Study Site 101, Fort Wayne
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
招募中1/2 期
- Fort Wayne Medical Oncology and Hematology, Fort Wayne
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
招募中3 期
- Parkview Research Center at Parkview Regional Medical Center ( Site 0002), Fort Wayne
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
招募中2 期
- Fort Wayne Oncology and Hematology, Fort Wayne
Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
招募中3 期
- Fort Wayne Medical Oncology and Hematology, Fort Wayne
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
招募中1 期
- American Oncology Partners, Fort Wayne
其他城市的 慢性淋巴细胞白血病试验
- Boston, MA31 项研究
- Columbus, OH28 项研究
- Durham, NC27 项研究
- Washington, DC22 项研究
- Seattle, WA20 项研究
- Rochester, MN18 项研究
- New York City, NY18 项研究
- Houston, TX17 项研究
- Baldwin Park, CA16 项研究
- Milwaukee, WI15 项研究
- Chicago, IL14 项研究
- Cincinnati, OH14 项研究
Fort Wayne的其他研究
- 非小细胞肺癌17 项研究
- 卵巢癌8 项研究
- 癌症（所有类型）7 项研究
- 乳腺癌7 项研究
- 肺癌6 项研究
- 转移性癌症6 项研究
- 子宫内膜癌5 项研究
- 黑色素瘤4 项研究
- 头颈鳞状细胞癌4 项研究
- 三阴性乳腺癌4 项研究
- 结直肠癌4 项研究
- 多发性骨髓瘤4 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。